Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial | Zendy

Areoo Samaei | Zendy; Kamyar Moradi | Zendy; Sayna Bagheri | Zendy; Amir AshrafGanjouei | Zendy; Rosa Alikhani | Zendy; S. Bentolhoda Mousavi | Zendy; Farzin Rezaei | Zendy; Shahin Akhondzadeh | Zendy

Open Access

Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial

Author(s) -

Areoo Samaei,

Kamyar Moradi,

Sayna Bagheri,

Amir AshrafGanjouei,

Rosa Alikhani,

S. Bentolhoda Mousavi,

Farzin Rezaei,

Shahin Akhondzadeh

Publication year - 2020

Publication title -

the international journal of neuropsychopharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.897

H-Index - 107

eISSN - 1469-5111

pISSN - 1461-1457

DOI - 10.1093/ijnp/pyaa006

Subject(s) - placebo , risperidone , tolerability , medicine , positive and negative syndrome scale , schizophrenia (object oriented programming) , extrapyramidal symptoms , randomized controlled trial , psychopathology , rating scale , psychology , psychiatry , adverse effect , psychosis , antipsychotic , developmental psychology , alternative medicine , pathology

Patients with schizophrenia can generally manifest a broad variety of primary negative symptoms. The current study aimed to assess the efficacy and tolerability of resveratrol add-on therapy in the treatment of negative symptoms in patients with stable schizophrenia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research